Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects

Rudolf A. Werner, Alvaro A. Ordonez, Julian Sanchez-Bautista, Charles Marcus, Constantin Lapa, Steven P. Rowe, Martin G. Pomper, Jeffrey P. Leal, Martin A. Lodge, Mehrbod S. Javadi, Sanjay K. Jain, Takahiro Higuchi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The novel PET probe 2-deoxy-2-18F-fluoro-d-sorbitol (18F-FDS) has demonstrated favorable renal kinetics in animals. We aimed to elucidate its imaging properties in 2 human volunteers. 18F-FDS was produced by a simple 1-step reduction from 18F-FDG. On dynamic renal PET, the cortex was delineated and activity gradually transited in the parenchyma, followed by radiotracer excretion. No adverse effects were reported. Given the higher spatiotemporal resolution of PET relative to conventional scintigraphy, 18F-FDS PET offers a more thorough evaluation of human renal kinetics. Due to its simple production from 18F-FDG, 18F-FDS is virtually available at any PET facility with radiochemistry infrastructure.

Original languageEnglish
Pages (from-to)410-411
Number of pages2
JournalClinical Nuclear Medicine
Volume44
Issue number5
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Sorbitol
Kidney
Fluorodeoxyglucose F18
Radiochemistry
Radionuclide Imaging
Volunteers

Keywords

  • 18F-FDS
  • 2-deoxy-2-18F-fluoro-d-sorbitol
  • kidney
  • PET
  • renal imaging
  • split renal function

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Werner, R. A., Ordonez, A. A., Sanchez-Bautista, J., Marcus, C., Lapa, C., Rowe, S. P., ... Higuchi, T. (2019). Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects. Clinical Nuclear Medicine, 44(5), 410-411. https://doi.org/10.1097/RLU.0000000000002494

Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects. / Werner, Rudolf A.; Ordonez, Alvaro A.; Sanchez-Bautista, Julian; Marcus, Charles; Lapa, Constantin; Rowe, Steven P.; Pomper, Martin G.; Leal, Jeffrey P.; Lodge, Martin A.; Javadi, Mehrbod S.; Jain, Sanjay K.; Higuchi, Takahiro.

In: Clinical Nuclear Medicine, Vol. 44, No. 5, 01.05.2019, p. 410-411.

Research output: Contribution to journalArticle

Werner, RA, Ordonez, AA, Sanchez-Bautista, J, Marcus, C, Lapa, C, Rowe, SP, Pomper, MG, Leal, JP, Lodge, MA, Javadi, MS, Jain, SK & Higuchi, T 2019, 'Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects', Clinical Nuclear Medicine, vol. 44, no. 5, pp. 410-411. https://doi.org/10.1097/RLU.0000000000002494
Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP et al. Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects. Clinical Nuclear Medicine. 2019 May 1;44(5):410-411. https://doi.org/10.1097/RLU.0000000000002494
Werner, Rudolf A. ; Ordonez, Alvaro A. ; Sanchez-Bautista, Julian ; Marcus, Charles ; Lapa, Constantin ; Rowe, Steven P. ; Pomper, Martin G. ; Leal, Jeffrey P. ; Lodge, Martin A. ; Javadi, Mehrbod S. ; Jain, Sanjay K. ; Higuchi, Takahiro. / Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects. In: Clinical Nuclear Medicine. 2019 ; Vol. 44, No. 5. pp. 410-411.
@article{3d1a3ed96077435583dda4c1aae83680,
title = "Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects",
abstract = "The novel PET probe 2-deoxy-2-18F-fluoro-d-sorbitol (18F-FDS) has demonstrated favorable renal kinetics in animals. We aimed to elucidate its imaging properties in 2 human volunteers. 18F-FDS was produced by a simple 1-step reduction from 18F-FDG. On dynamic renal PET, the cortex was delineated and activity gradually transited in the parenchyma, followed by radiotracer excretion. No adverse effects were reported. Given the higher spatiotemporal resolution of PET relative to conventional scintigraphy, 18F-FDS PET offers a more thorough evaluation of human renal kinetics. Due to its simple production from 18F-FDG, 18F-FDS is virtually available at any PET facility with radiochemistry infrastructure.",
keywords = "18F-FDS, 2-deoxy-2-18F-fluoro-d-sorbitol, kidney, PET, renal imaging, split renal function",
author = "Werner, {Rudolf A.} and Ordonez, {Alvaro A.} and Julian Sanchez-Bautista and Charles Marcus and Constantin Lapa and Rowe, {Steven P.} and Pomper, {Martin G.} and Leal, {Jeffrey P.} and Lodge, {Martin A.} and Javadi, {Mehrbod S.} and Jain, {Sanjay K.} and Takahiro Higuchi",
year = "2019",
month = "5",
day = "1",
doi = "10.1097/RLU.0000000000002494",
language = "English",
volume = "44",
pages = "410--411",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects

AU - Werner, Rudolf A.

AU - Ordonez, Alvaro A.

AU - Sanchez-Bautista, Julian

AU - Marcus, Charles

AU - Lapa, Constantin

AU - Rowe, Steven P.

AU - Pomper, Martin G.

AU - Leal, Jeffrey P.

AU - Lodge, Martin A.

AU - Javadi, Mehrbod S.

AU - Jain, Sanjay K.

AU - Higuchi, Takahiro

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The novel PET probe 2-deoxy-2-18F-fluoro-d-sorbitol (18F-FDS) has demonstrated favorable renal kinetics in animals. We aimed to elucidate its imaging properties in 2 human volunteers. 18F-FDS was produced by a simple 1-step reduction from 18F-FDG. On dynamic renal PET, the cortex was delineated and activity gradually transited in the parenchyma, followed by radiotracer excretion. No adverse effects were reported. Given the higher spatiotemporal resolution of PET relative to conventional scintigraphy, 18F-FDS PET offers a more thorough evaluation of human renal kinetics. Due to its simple production from 18F-FDG, 18F-FDS is virtually available at any PET facility with radiochemistry infrastructure.

AB - The novel PET probe 2-deoxy-2-18F-fluoro-d-sorbitol (18F-FDS) has demonstrated favorable renal kinetics in animals. We aimed to elucidate its imaging properties in 2 human volunteers. 18F-FDS was produced by a simple 1-step reduction from 18F-FDG. On dynamic renal PET, the cortex was delineated and activity gradually transited in the parenchyma, followed by radiotracer excretion. No adverse effects were reported. Given the higher spatiotemporal resolution of PET relative to conventional scintigraphy, 18F-FDS PET offers a more thorough evaluation of human renal kinetics. Due to its simple production from 18F-FDG, 18F-FDS is virtually available at any PET facility with radiochemistry infrastructure.

KW - 18F-FDS

KW - 2-deoxy-2-18F-fluoro-d-sorbitol

KW - kidney

KW - PET

KW - renal imaging

KW - split renal function

UR - http://www.scopus.com/inward/record.url?scp=85064284928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064284928&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000002494

DO - 10.1097/RLU.0000000000002494

M3 - Article

C2 - 30762825

AN - SCOPUS:85064284928

VL - 44

SP - 410

EP - 411

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 5

ER -